AU2001261394A1 - Reverse isotope dilution assay and lactose intolerance assay - Google Patents

Reverse isotope dilution assay and lactose intolerance assay

Info

Publication number
AU2001261394A1
AU2001261394A1 AU2001261394A AU6139401A AU2001261394A1 AU 2001261394 A1 AU2001261394 A1 AU 2001261394A1 AU 2001261394 A AU2001261394 A AU 2001261394A AU 6139401 A AU6139401 A AU 6139401A AU 2001261394 A1 AU2001261394 A1 AU 2001261394A1
Authority
AU
Australia
Prior art keywords
assay
lactose intolerance
isotope dilution
reverse
reverse isotope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261394A
Inventor
David A Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolic Solutions Inc
Original Assignee
Metabolic Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Solutions Inc filed Critical Metabolic Solutions Inc
Publication of AU2001261394A1 publication Critical patent/AU2001261394A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Atmospheric Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001261394A 2000-05-18 2001-05-10 Reverse isotope dilution assay and lactose intolerance assay Abandoned AU2001261394A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20534200P 2000-05-18 2000-05-18
US60205342 2000-05-18
PCT/US2001/015143 WO2001087352A1 (en) 2000-05-18 2001-05-10 Reverse isotope dilution assay and lactose intolerance assay

Publications (1)

Publication Number Publication Date
AU2001261394A1 true AU2001261394A1 (en) 2001-11-26

Family

ID=22761806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261394A Abandoned AU2001261394A1 (en) 2000-05-18 2001-05-10 Reverse isotope dilution assay and lactose intolerance assay

Country Status (4)

Country Link
US (1) US6902719B2 (en)
JP (1) JP2003533680A (en)
AU (1) AU2001261394A1 (en)
WO (1) WO2001087352A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE502578T1 (en) * 2001-10-24 2011-04-15 Univ California MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND IN EXPERIMENTAL SYSTEMS BY USING ISOTOPICALLY LABELED WATER
WO2003068919A2 (en) 2002-02-12 2003-08-21 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
WO2003071271A1 (en) * 2002-02-21 2003-08-28 Tokyo Gas Company Limited Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof
KR20040096618A (en) 2002-02-27 2004-11-16 캠브리지 이소토페 래버러토리즈사 Use of 13C labelled substance for measuring lung function
CA2494715C (en) 2002-07-30 2014-07-08 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry
US20060105339A1 (en) * 2002-09-04 2006-05-18 Marc Hellerstein Methods for measuring the rates of replication and death of microbial infectious agents in an infected
SG149699A1 (en) * 2002-09-13 2009-02-27 Univ California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
US20070248540A1 (en) * 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
JP4611025B2 (en) * 2002-11-04 2011-01-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Deuterated glucose or fat tolerance test for high-throughput measurement of glucose or fatty acid metabolism in the body
AU2003902390A0 (en) * 2003-05-16 2003-06-05 Women's And Children's Hospital Non-invasive method of assessing gastrointestinal damage
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
EP1723252A4 (en) * 2004-03-11 2009-07-29 Univ California Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
WO2005094327A2 (en) * 2004-03-29 2005-10-13 The Regents Of The University Of California Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
JP4118918B2 (en) * 2005-02-28 2008-07-16 シャープ株式会社 Signal quality evaluation apparatus, information recording / reproducing apparatus, signal quality evaluation method, recording condition determination method, signal quality evaluation program, and computer-readable recording medium recording the signal quality evaluation program
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
WO2008057265A2 (en) * 2006-10-27 2008-05-15 University Of Maryland Single nucleotide polymorphisms and the identification of lactose intolerance
US8163074B2 (en) 2007-02-06 2012-04-24 Xerox Corporation Phase change inks containing colorant compounds
JP2014526685A (en) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア Metabolic flow measurement, imaging, and microscopy
CA2858368A1 (en) 2011-12-07 2013-06-13 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
US20150250407A1 (en) * 2012-03-14 2015-09-10 Anastasia Rigas Breath analyzer and breath test methods
EP3145403A4 (en) 2012-03-14 2018-01-24 Anastasia Rigas Breath analyzer and breath test methods
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
EP2946722A1 (en) 2014-05-20 2015-11-25 Sensirion AG Portable electronic device for breath sampling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer

Also Published As

Publication number Publication date
WO2001087352A1 (en) 2001-11-22
US20020159950A1 (en) 2002-10-31
JP2003533680A (en) 2003-11-11
US6902719B2 (en) 2005-06-07

Similar Documents

Publication Publication Date Title
AU2001261394A1 (en) Reverse isotope dilution assay and lactose intolerance assay
AU2001275340A1 (en) Integrated active flux microfluidic devices and methods
AU2001247478A1 (en) Microlaboratory devices and methods
AU3334501A (en) Construction element and joining member
AU2001243991A1 (en) Sandwich wall construction and dwelling
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2001235988A1 (en) Solenoid
AU4843500A (en) Destructible surfactants and uses thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001248817A1 (en) Form panel and panel holding member
AU2001259667A1 (en) Electrostatographic blender assembly and method
AU2001236141A1 (en) Immunoassay and diagnostic reagent for malaria
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2633501A (en) Machine element/assembly and magneform joint
AU2002316577A1 (en) Cell-screening assay and composition
EP1302770A4 (en) Particle-labeled protein and immuno-chromatograph using the same
AU2001259730A1 (en) Standardized oxidized ldl assay
AU2001269276A1 (en) Drills and their manufacture
AU2001257108A1 (en) Yarn strength enhancing agents and compositions and methods employing same
AU2001291962A1 (en) Angiogenic agents and their uses
AU2001260229A1 (en) Building construction and shaped elements for erecting the same
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2001285297A1 (en) Work sharing and communicating
AU5240901A (en) Assay